SPHK1 and colorectal carcinoma: For instance, miR-659-3p negatively regulates SphK1 in chronic myeloid leukemia and CRC, leading to inhibition of cell proliferation, induction of apoptosis, and regulation of resistance to chemotherapy [195, 196].